| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 120.060 | 137.237 | 130.895 | 77.347 | 103.892 | 64.996 | 81.450 | 85.293 | 102.926 | 59.759 |
| Total Income - EUR | 120.155 | 137.260 | 131.775 | 79.161 | 107.268 | 65.603 | 83.172 | 85.294 | 103.021 | 59.760 |
| Total Expenses - EUR | 88.791 | 78.942 | 73.226 | 68.502 | 84.123 | 56.482 | 73.066 | 74.725 | 95.173 | 71.193 |
| Gross Profit/Loss - EUR | 31.364 | 58.318 | 58.549 | 10.659 | 23.146 | 9.121 | 10.106 | 10.568 | 7.848 | -11.433 |
| Net Profit/Loss - EUR | 25.335 | 48.124 | 56.749 | 9.868 | 22.073 | 8.619 | 9.340 | 9.809 | 6.931 | -11.965 |
| Employees | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Oftaclinic Optic Grup Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 34.819 | 39.751 | 31.374 | 123.941 | 157.449 | 189.122 | 191.057 | 173.997 | 154.100 | 135.205 |
| Current Assets | 39.685 | 24.407 | 37.155 | 36.521 | 19.952 | 17.888 | 11.987 | 9.480 | 12.937 | 19.357 |
| Inventories | 6.170 | 9.051 | 7.925 | 7.221 | 7.098 | 5.135 | 5.363 | 6.449 | 3.443 | 4.754 |
| Receivables | 26.358 | 13.502 | 12.996 | 410 | 3.067 | 2.909 | 3.997 | 461 | 1.315 | 2.296 |
| Cash | 1.703 | 1.854 | 16.234 | 28.890 | 9.787 | 9.844 | 2.627 | 2.570 | 8.179 | 12.308 |
| Shareholders Funds | 68.821 | 54.666 | 63.181 | 71.890 | 92.570 | 99.434 | 106.569 | 116.708 | 123.285 | 110.632 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 6.075 | 9.994 | 5.718 | 88.933 | 85.258 | 107.924 | 96.827 | 67.357 | 44.438 | 44.510 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Oftaclinic Optic Grup Srl